Background
==========

Amelogenesis imperfecta (AI) is a group of inherited defects of dental enamel formation that show both clinical and genetic heterogeneity \[[@B1]\]. In its mildest form, AI causes discoloration, while in the most severe presentation the enamel is hypocalcified causing it to be abraded from the teeth shortly after their emergence into the mouth \[[@B2]\]. Both the primary and permanent dentitions may be affected. Enamel findings in AI are highly variable, ranging from deficient enamel formation to defects in the mineral and protein content \[[@B3]\]. Four main types of AI have been described: hypoplastic, hypocalcified, hypomaturation and hypomaturation-hypoplastic with taurodontism \[[@B4]\].

The AI phenotypes vary widely depending on the specific gene involved, the location and type of mutation, and the corresponding putative change at the protein level \[[@B5]\]. Different inheritance patterns such as X-linked, autosomal dominant and autosomal recessive types have been reported and 14 subtypes of AI are recognized \[[@B4]\].

The distribution of AI types is known to vary in different populations \[[@B3]\], suggesting allele frequency differences between ethnic groups \[[@B6]\]. The combined prevalence of all forms of AI has been reported as 1:14000 in the U.S. \[[@B7]\], 1:8000 in Israel \[[@B6]\] and 1:4000 in Sweden \[[@B8]\]. The autosomal dominant form of AI is most prevalent in the United States and Europe, while autosomal recessive AI is most prevalent in the Middle East \[[@B6],[@B7]\]. Different mutations in genes that encode principal matrix proteins and proteinases of enamel have been associated with the different phenotypes of AI.

The main structural proteins in forming enamel are amelogenin, ameloblastin, and enamelin. These proteins are proteolytically cleaved following their secretion. Some of the cleavage products accumulate in the enamel layer, while others are either degraded or reabsorbed by ameloblasts \[[@B9]\]. Different proteinases such as matrix metalloproteinase-20 and kallikrein-4, regulate the enamel matrix protein processing that ultimately defines the structure and composition of enamel \[[@B10]\].

Amelogenin, the protein product of the *AMELX*Xp22.3-p22.1 and *AMELY*Yp11 genes, is considered to be critical for normal enamel thickness and structure \[[@B11]\]. Amelogenin is the most abundant protein in developing enamel, accounting for more than 90% of total enamel protein \[[@B12]\], while ameloblastin and enamelin account for about 5% and 2% of total protein, respectively \[[@B9]\]. Amelogenin is thought to form a scaffold for enamel crystallites and to control their growth \[[@B11]\], but its exact functions are not fully known \[[@B13]\]. At least 14 mutations have been described in the X-chromosome amelogenin gene and are associated with hypoplastic and/or hypomineralization AI \[[@B12]-[@B19]\]. However, no cases of mutation in the Y-chromosome amelogenin gene have been reported \[[@B13]\], due to the fact that, the amino acid sequence of the X and Y chromosome amelogenin genes are not the same and only the X copy is critical for normal enamel development.

The chromosome 4q13 region contains at least 3 genes important in enamel development: enamelin, ameloblastin, and amelotin. Enamelin gene mutations have been identified in autosomal dominant AI \[[@B1],[@B5],[@B20],[@B21]\]. Recently it was reported that transgenic mice overexpressing ameloblastin develop AI \[[@B22]\]. In ameloblastin null mutant mice, ameloblasts regain some early phenotypes of undifferentiated dental epithelial cells, and the abnormalities occur when the cells detach indicating that ameloblastin is an adhesion molecule key for enamel formation \[[@B23]\].

Recently a novel gene coding for an ameloblast-specific protein, amelotin, was mapped close to the amelobastin and enamelin genes. It was hypothesed that amelotin is involved primarily in the maturation of enamel and thus the formation of its unique biomechanical characteristics during tooth development \[[@B24],[@B25]\].

Mutations in the predominant enamel proteinases \[[@B9]\] have also been associated with AI. MMP20 is secreted into the enamel matrix in the secretory and transition developmental stages \[[@B10],[@B26],[@B27]\]. This enzyme accounts for most of the proteolytic activity of the enamel matrix and is thought to be responsible for the processing of the amelogenin protein causing the tyrosine-rich amelogenin peptide (TRAP) to form \[[@B28],[@B29]\]. Kallikrein-4 is thought to be the major enzyme responsible for the degradation of enamel proteins during the maturation stage, and has been shown to cleave amelogenin \[[@B30]\]. The human *MMP20*and *KLK4*genes map to chromosome 11 and 19, respectively \[[@B31]\]. Two different mutations in *MMP20*gene and one in *KLK4*gene confirm that mutations in theses genes have been associated with autosomal-recessive forms of AI \[[@B32],[@B33]\].

The purpose of this study was to evaluate evidence for a genetic etiology for the six major candidate gene loci (ENAM, AMBN, AMELX, MMP20, KLK4, Amelotin) in two Brazilian families segregating AI. All exons and intron-exon junctions of these genes were sequenced, and polymorphic DNA loci spanning candidate genes in seven chromosomal regions were genotyped to evaluate support for linkage. Results of these studies provide further evidence for genetic heterogeneity of AI.

Materials and methods
=====================

Family and phenotype analyses
-----------------------------

This study was carried out with the approval of the FOP/UNICAMP Ethics Committee (protocol 127/03) and informed consent was obtained from all subjects. Two families segregating AI were identified. All available family members were examined clinically and in some cases radiographically. Oral examinations included visual examination in a dental clinic using artificial light and dental mirror evaluations of teeth and supporting tissues. Affected and unaffected individuals were also evaluated clinically for the presence of skin, hair, fingernail and osseous abnormalities know to be associated with systemic or syndromic conditions that can be associated with enamel defects. No history of nutritional disturbances was reported by the affected members of the two families.

Affected status of family 1 was established clinically by the presence of a generalized yellow-brown discoloration of primary and permanent dentitions. The deficiency in the enamel mineral content was evidenced by a lack of radiographic enamel opacity and a pathological loss of enamel through wear and fracturing. The clinical phenotype and family history suggested an autosomal recessive hypocalcified AI (Fig [1](#F1){ref-type="fig"}).

![**Clinical phenotype and pedigree of Family 1**. Family 1: A phenotype demonstrating generalized yellow-brown discoloration of the dentition (A1 patient III-2, A2 patient III-5); B X-ray showing lack of enamel opacity and a pathological loss of enamel (B1 patient III-2, B2 patient III-5); C pedigree of Family 1.](1746-160X-3-8-1){#F1}

The enamel of affected members of family 2 was thin with rough and pitted surface (hypoplastic AI, Family 2). Both primary and permanent dentitions were affected. The clinical phenotype and family history did not allow determining the pattern of gene inheritance (Fig [2](#F2){ref-type="fig"}).

![**Clinical phenotype and pedigree of Family 2**. Family 2: A phenotype of patient III-4 demonstrating points of yellow-brown discoloration of the dentition, and areas with thin enamel. (A1 dentition, A2 detail); B radiographic patient III-4; C pedigree of Family 2 suggested X-link AI.](1746-160X-3-8-2){#F2}

Blood was obtained by venepuncture (Vacutainer system) and DNA extracted using Kit Puregene (Gentra Systems) for genotyping and sequence analysis.

Genotyping studies
------------------

Members of each family were evaluated for linkage to chromosomal regions known to contain genes important in enamel development at previously described \[[@B24],[@B32]-[@B38]\]. Table [1](#T1){ref-type="table"} shows studied markers for linkage to chromosome regions known to contain genes important in enamel development. The PCR reactions were performed using 20 ng of genomic DNA in a final volume of 7.5 μl, as reported previously \[[@B39]\]. All electrophoretic evaluations of the marker gene allele sizes were performed on an ABI 3100XL automated DNA sequencer using POP-7, 37 cm capillary and an internal size standard (ROX GS 400 standard (Applied Biosystems, Foster City, CA, USA)). Allele calling was done using the genescan software (Applied Biosystems, Foster City, CA, USA).

###### 

Markers for linkage to chromosome regions known to contain genes important in enamel development

  Markers    Label   ASR        Markers   Label   ASR        Markers   Label   ASR
  ---------- ------- ---------- --------- ------- ---------- --------- ------- ----------
  D1S252     VIC     86--112    D19S902   FAM     237--273   DXS1060   NED     244--268
  D1S498     NED     187--209   D19S904   FAM     213--229   DXS8051   NED     104--134
  D1S305     FAM     156--176   D19S246   FAM     185--233   DXS987    FAM     267--293
  D1S1153    VIC     270--404   D19S571   NED     289--319   DXS1226   NED     280--302
  D4S719     FAM     250--300   D20S117   FAM     151--187   DXS1214   VIC     284--298
  AMBN       VIC     250--280   D20S889   FAM     87--123    DXS1068   VIC     244--264
  922H22     NED     350        D20S115   NED     234--246   DXS993    FAM     267--293
  D4S2964    FAM     120        D20S186   VIC     113--139   DXS991    NED     313--341
  D7S284     HEX     272--307   D20S112   FAM     213--237   DXS986    FAM     151--181
  D7S272     VIC     211--261   D20S195   FAM     128--154   DXS990    FAM     122--132
  D7S1837    FAM     193--210   D20S107   FAM     197--221   DXS1106   VIC     126--140
  D7S1743    VIC     88--188    D20S178   NED     179--195   DXS8055   VIC     312--324
  D11S898    FAM     141--165   D20S196   NED     259--295   DXS1001   VIC     191--211
  D11S1391   TET     158--178   D20S100   VIC     209--235   DXS1047   VIC     156--172
  D11S1347   HEX     177--203   D20S171   VIC     127--155   DXS1227   FAM     79--99
  D11S908    VIC     172--190   D20S173   VIC     128--182   DXS8043   NED     146--180
  D11S4090   FAM     161--189                                DXS8091   VIC     80--102
                                                             DXS1073   FAM     306--334

ASR: Allele Size Range (base pairs)

Mutation analysis
-----------------

PCRs were carried out in a *Perkin-Elmer GeneAmp 2400*thermal cycler and total volume of 50 μl, containing 500 ng genomic DNA, 10 mM Tris-HCl (pH 8,3), 50 mM KCl, 1.5 mM MgCl~2~, 1 μM of each primer, 200 mM each dNTPs, and 1 units Taq DNA polymerase (Amersham Pharmacia Biotech AB, Uppsala, Sweden). PCR was performed by an initial denaturation at 95°C for 5 min, followed by 35 cycles of 1 min at 95°C, annealing for 1 min at temperature listed in Table [2](#T2){ref-type="table"}, extension at 72°C for 1 min, and a final extension at 72°C for 7 min. The primer sequences and PCR conditions are shown in Table [2](#T2){ref-type="table"}.

###### 

The primer sequences and PCR conditions

  ***Gene***          ***Primer*(5\' -- 3\')**           **AT bp**   ***Gene***         ***Primer*(5\' -- 3\')**            **AT bp**
  ------------------- ---------------------------------- ----------- ------------------ ----------------------------------- -----------
  **MMP20**           **F:**AAGTGCAAACGTGCACTGTC         68°C        **ENAM**           **F:**GAGACTTGACTTGACAGCTCCTAT      60°C
  ***Exon 1***        **R:**GGTTTTCTAGGGCAGAGGAG         170         ***Exon 1***       **R:**TCTCTAATACTCACCCAATGCC        413
  **MMP20**           **F:**ACTACGCTGTAGACGCGTCA         58°C        **ENAM**           **F:**CAAAGACAAGCTAACAAAGTTCAA      58°C
  ***Exon 2***        **R:**CTCTGAATTTGCAAAGACTTG        318         ***Exon 1 -3***    **R:**GCCCTCTCAAGTGTATTTCTGACA      735
  **MMP20**           **F:**GAAAACATGTTCCTTCCGTT         58°C        **ENAM**           **F:**GCAGCTTGAAAACTACCAGATGAT      58°C
  ***Exon 3***        **R:**AGATGGAATCCAAGTACCAC         201         ***Exon 4 e 5***   **R:**ACTTTGCCTCGATTTGAGAGTTTA      573
  **MMP20**           **F:**GAAGGACTCAATCTTGTTGGC        62°C        **ENAM**           **F:**CACTGGGAAGTTCTAAGGTT          58°C
  ***Exon 4***        **R:**CCAGGTTATGGTGAATTGTGC        196         ***Exon 6***       **R:**AACGGAGTTATCTAGATAAACAAG      212
  **MMP20**           **F:**CCTGTGTTGATACTGTTTTTTTC      60°C        **ENAM**           **F:**CAGCCTGAATCACAGCTCTATT        58°C
  ***Exon 5***        **R:**GGGTGGTCATCAAAGAAGG          234         ***Exon 7***       **R:**TTAAAAGGCAACAGTATTTGGGTA      513
  **MMP20**           **F:**CCCGTTACCATTTTGACCAAC        60°C        **ENAM**           **F:**TTATCATTATCGTCTTTGCCCTAT      58°C
  ***Exon 6***        **R:**AATGAGAGTCGGTGGCGTGT         210         ***Exon 8***       **R:**CCCAGTTTCCCCATTACATT          567
  **MMP20**           **F:**GTAAATCAATCATTGATCTTG        56°C        **ENAM**           **F:**TCGAAGGTGGTTTTCTCCTGTGTT      58°C
  ***Exon 7***        **R:**GCCATTTCTTTCTTTGAGGG         226         ***Exon 9***       **R:**AGCAGGGGCGAATGGATTGT          157
  **MMP20**           **F:**GGTGCAGAGTTTTCGTAAAC         52°C        **ENAM**           **F:**AACACCATGGTGGGAAACAAAG        58°C
  ***Exon 8***        **R:**AAATAAAGATAGATAGTAAAAAGG     232         ***Exon 10.1***    **R:**TTACGTTCCCAAGCAAAGAAGTTC      573
  **MMP20**           **F:**CATCTACAACCAGTAAAAACC        58°C        **ENAM**           **F**: ACAGAATAGGCCTTTTTACAGA       60°C
  ***Exon 9***        **R:**GCAAAGCCAAGATTTCTTATG        223         ***Exon 10.2***    **R:**ATTGGGTTATATTCAGGGTAGAA       787
  **AMELX**           **F**: GGATTGGTTGTTACAGATGCC       59°C        **ENAM**           **F:**CAAGAAGAACATTTACCCCATCCT      60°C
  ***Exon 1***        **R:**TGGGCCAACTAAAAAGTAAC         252         ***Exon 10.3***    **R:**CATGCCATAGTTCAAATTCTCACC      753
  **AMELX**           **F:**TGTGTTTTATGGAGCATTCA         65°C        **ENAM**           **F:**AGCTGGGCTTCAGAAAAATCCAAT      60°C
  ***Exon 2***        **R:**TTACTCACAGGCATGGCAAAAGCTGC   148         ***Exon 10.4***    **R:**AGATGGTCTTTGCTGTTGCCTCTC      709
  **AMELX**           **F:**CCTCCCTGTAAAAGCTACCACC       67°C        **ENAM**           **F:**CTCCAATCCAGAAGGCATCCAA        60°C
  ***Exon 3***        **R:**CTTTACAGAGCCCAGGGCATTG       126         ***Exon 10.5***    **R:**CTCCACCTGGGTCGCTACTCCTAT      510
  **AMELX**           **F:**GTAGAACTCACATTCTCAGGC        67°C        **KLK4**           **F:**GCAGCTTTGCAGTCACAAGC          58°C
  ***Exon 4e 5***     **R:**AATGTCTACATACCGGTGGCC        292         ***Exon 1***       **R:**AGGGACAAAGAGAGGGATGG          150
  **AMELX**           **F:**GTAGAACTCACATTCTCAGGC        67°C        **KLK4**           **F:**TGACTGCTCCTGAACCTCTG          58°C
  ***Exon 6***        **R:**GGCTTCAAAATATACTCACCACTTCC   994         ***Exon 2***       **R:**ATGAGCCTGATATTAGGCCC          334
  **AMELX**           **F:**CATCTACAACCAGTAAAAACC        67°C        **KLK4**           **F:**TTCTCCACCCTTCCCTGAGT          58°C
  ***Exon7***         **R:**GCAAAGCCAAGATTTCTTATG        223         ***Exon 3 e 4***   **R:**TGCCACAAAACTGACCTGCC          555
  **AMBN**            **F:**ATTGCAGGAGCAGAGATTCC         58°C        **KLK4**           **F:**GAATTCTGACTCTCCCTCTC          58°C
  ***Exon 1***        **R:**TGGGTGTTAGGCATGTCATC         395         ***Exon 5***       **R:**GGTCAATTTCATGGGTTCCC          214
  **AMBN**            **F:**CCTTTATCCCGGTGGTTTTT         58°C        **Amelotin**       **F:**CTGCAGCTAATAACCCACCTAATGA     58°C
  ***Exon 2***        **R:**CGCTTTTGGATTGCAAGACT         365         ***Exon 1 e 2***   **R:**AATTGACCTTTTACCACGATGGA       636
  **AMBN**            **F:**CTTCTTCATTCTGCCCAAGC         58°C        **Amelotin**       **F:**GGGCTGGCATTTTTCCACTCTACAT     58°C
  ***Exon 3***        **R:**TGCAGTAGAATTATAAGACAAAGCTC   385         ***Exon 3***       **R:**TTTTCCCCACTCCCAAACGA          437
  **AMBN**            **F:**TCCACCTTTCAGTGATGATTTG       58°C        **Amelotin**       **F:**CGAGGCTTCATCTTTATTTACCTTC     58°C
  ***Exon 4***        **R:**TTGTTTTTGTTTTTCCCTGTCA       376         ***Exon 4***       **R:**CATTTGTGGATATACGCACCC         306
  **AMBN**            **F:**CTGGCGACAGAGCAAGATTC         58°C        **Amelotin**       **F:**GCAATAGCCCTTGTAGTCGTAC        58°C
  ***Exon 5***        **R:**TCGATTTATTTGGCACGAGA         370         ***Exon 5***       **R:**GCATGGTCAGTTCTCTGGGTATGTT     496
  **AMBN**            **F:**TCCTAGCCTCCCTTCCAGAT         58°C        **Amelotin**       **F:**GGCATAGTAGCAGGCAACTGT         58°C
  ***Exon 6***        **R:**TTATGCCTGAAGGCTACGATT        452         ***Exon 6***       **R:**ACAAAGTACATTGGAAACCTCACAA     358
  **AMBN**            **F:**TTGGGTCATACCTCCCAAAA         58°C        **Amelotin**       **F:**ATAGATCATAAGGCAGTTTAACATATT   58°C
  ***Exon 7--9***     **R:**TCATGGATAAATGGGACAATGA       670         ***Exon 7***       **R:**TAGAAAAGTAGCTGGAGAAGTATAATG   373
  **AMBN**            **F:**TCATGGATAAATGGGACAATGA       58°C        **Amelotin**       **F:**CTCCATCTTTCCATTCCTACCCA       58°C
  ***Exon 10--12***   **R:**CTGAGTCCCATGATCATTTG         950         ***Exon 8***       **R:**GAGTAAAAATATTCCCTCATGTTGCT    527
  **AMBN**            **F:**CAGCCAACTTCCTATTCTCCA        58°C        **Amelotin**       **F:**CTAAAGAATGATATGGATGCTCCTAAT   58°C
  ***Exon 13***       **R:**AAAGCAAGAAGGGGACCTACA        842         ***Exon 9***       **R:**GAGACCAGAATTTGTCTTCACATTGC    567

The PCR products were electrophoresed through 1% agarose gels and the amplicons extracted using GFX™ PCR DNA and Gel Band Purification Kit *(Amersham Pharmacia Biotech)*. Extracted amplicons were sequenced using *do Big Dye Terminator Kit (Perkin Elmer) and an ABI Prism 377 DNA Sequencer*™.

Results and Discussion
======================

Examinations of all affected and unaffected members from both families studied indicated 4 of the 17 family members evaluated were affected (2 members affected in each family). Affected individuals showed no signs of syndromic conditions or systemic illnesses associated with defective enamel development. None of the unaffected family members had generalized enamel defects clinically and showed no evidence of radiographic enamel defects, taurodontism or dental abnormalities. There was variability in the severity of expression of the AI phenotype in family 2. Individual III-4 of family 2 showed more severe pitting than his mother (individual II-6). This difference in severity between males and females may be indicative of X-linked AI form. The presence of only one male and one female affected, however, did not allow confirming this pattern of inheritance. Additionally sequencing of amelogenin X gene did not reveal any mutations in this gene that could be associated with enamel phenotype. Radiographically, enamel was very thin but in some areas it was possible to note that enamel displayed a radiodensity similar to that of normal enamel (Fig. [2](#F2){ref-type="fig"}).

Affected individuals of family 1 reported variable dental hypersensitivity ranging from mild dental discomfort with thermal or chemical stimulation to normal dental sensitivity. Radiographically the teeth displayed enamel that had a radiodensity similar to that of dentin (Fig. [1](#F1){ref-type="fig"}).

A number of genes involved in enamel formation have been identified, and based on their expression and function, several of these genes have been proposed as candidates for AI. This study all available family members were genotyped for multiple short tandem repeat polymorphism (STRP) type markers spanning each AI candidate gene locus. Haplotyped genotype results did not show support for linkage to any of the chromosomal regions tested, clearly rejecting the linkage hypothesis throughout all six candidate regions.

The exons and intron/exon junctions of the *AMELX, ENAM, AMBN, MMP20, KLK4*and Amelotin genes were sequenced and no gene mutations were identified in any individuals. A novel polymorphism was identified in the amelotin gene next exon 5 this gene. This SNP is characterized by a change of A to G in base 7125 (NCBI35:4:71564458:71579819:1). However, this SNP does not change the amino acid coded for by the triplet codon sequence and, therefore, does not appear to be associated with AI in the studied families. Figure [3](#F3){ref-type="fig"} shows the position of this polymorphism.

![A single nucleotide polymorphism in amelotin gene: change of A to G in base 7125 (NCBI35:4:71564458:71579819:1).](1746-160X-3-8-3){#F3}

While we did not find exon mutations, it is possible that others types of mutations may be involved, such as promoter or intron mutations or deletions that encompass whole exons. However, results of the genotyping analyses do not support genetic linkage to the interval, suggesting that theses regions are not involved with AI in the studied families.

Others failed to show association between mutation in known genes involved in enamel formation and AI \[[@B40]\]. It has been known for some time that defects in known and suspected candidate genes can not explain all AI cases. Kim *et al*. (2006) \[[@B41]\] showed that the current list of AI candidate genes was insufficient to identify the causative gene defect in most families studied, suggesting that unknown genes/proteins that are critical for dental enamel formation. Our results indicate that additional locus coding for genes involved in ameloblast cytodifferentiation and function remain unidentified. Recently, Mendoza *et al*. (2006) \[[@B42]\] have mapped a new locus for autosomal dominant amelogenesis imperfecta on the long arm of chromosome 8 at 8q24.3.

In this study, exclusion of six candidate genes suggests that this common AI type is caused by alteration of a gene that is either not known or not considered to be a major contributor to enamel formation. Continued mutational analysis of families with AI will allow a comprehensive standardized nomenclature system to be developed for this group of disorders that will include molecular delineation as well as a mode of inheritance and phenotype.

Conclusion
==========

The present study indicates that the autosomal recessive hypocalcified and a hypoplastic form of AI in two distinct families are not caused by mutations in any of the known loci for amelogenesis imperfecta. This suggests that many additional genes potentially contribute to the etiology of AI.
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